Published in Medical Letter on the CDC and FDA, May 19th, 2002
The Indianapolis, Indiana-based pharmaceutical maker announced the effort in Atlanta, Georgia, at the opening of the March 2002 International Conference on Emerging Infectious Diseases.
The training program, which involves bringing foreign scientists to U.S. government labs and Lilly's headquarters, is in part a response to the events of September 11 and subsequent anthrax attacks.
Overseeing the effort will be the National...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA